<DOC>
	<DOCNO>NCT01797133</DOCNO>
	<brief_summary>We conduct cluster randomize control trial compare two antibiotic pre-authorization strategy ( Fellow-based vs. Pharmacist-based ) . We believe amount duration antibiotic consumption would lower pharmacist group clinical outcome would equivalent two group .</brief_summary>
	<brief_title>A Comparative Study ID Fellow-based VS. Pharmacist-based Antibiotic Pre-authorization</brief_title>
	<detailed_description>Study design : A cluster randomize control trial Settings : 6 general medical ward Siriraj Hospital , Bangkok , Thailand</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Hospitalized patient Received least one dose control antibiotic ( Piperacillin/Tazobactam , Imipenem/Cilastatin , Meropenem Doripenem ) Each patient may enrol , he/she receives control antibiotic new episode infection ( least 48 hour apart ) Died prior receive control antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>